Enanta Pharma loses appeal in Pfizer Paxlovid patent case
Go back to Enanta Pharma loses appeal in Pfizer Paxlovid patent case| ENANTA PHARM (NASDAQ: ENTA) | Delayed: 13.06 -0.36 (2.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.42 | 52 Week High | $34.49 | |||
| Open | $13.36 | 52 Week Low | $20.39 | |||
| Day High | $13.82 | P/E | N/A | |||
| Day Low | $13.01 | EPS | $-3.18 | |||
| Volume | 153,951 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 24.82 -0.12 (0.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.94 | 52 Week High | $37.39 | |||
| Open | $25.18 | 52 Week Low | $28.25 | |||
| Day High | $25.19 | P/E | 15.04 | |||
| Day Low | $24.78 | EPS | $1.65 | |||
| Volume | 32,977,136 | |||||
